Trial
|
Studied treatment |
Control |
Patients |
Size |
Study type
|
Results |
NCT |
Acute coronary syndrome - antithrombotics in all type of patients - antiplatelets drug in ACS (excluding AMI) - antiplatelets drug in all type of patients - antiplatelets drug in STEMI patients |
STAI, 1990 | ticlopidine | control | | 652 (314/338) | | | |
Knudsen-A, 1985 | ticlopidine | control | | 43 (24/19) | | | |
Florida UA | ticlopidine | placebo | | 24 (12/12) | | | |
|
Knudsen-A, 1985 | ticlopidine | control | | 43 (24/19) | | | |
CABG surgery - antiplatelets drug in all type of patients |
Zurich, 1982 | ticlopidine | control | | 100 (50/50) | | | |
Knudsen-B, 1983 | ticlopidine | control | | 19 (9/10) | | | |
Romeo, 1983 | ticlopidine | control | | 40 (20/20) | | | |
Kohn, 1990 | ticlopidine | control | | 45 (21/24) | | | |
Liège-I, 1984 | ticlopidine | placebo | | 150 (75/75) | | | |
Liège-II, 1987 | ticlopidine | placebo | | 175 (88/87) | | | |
Cardiovascular prevention - antiplatelets drug in secondary prevention in patients with intermittent claudication - antiplatelets drug in secondary prevention in patients with CAD - antiplatelets drug in diabetic patients |
Ellis, 1986 | ticlopidine | placebo | | 203 (100/103) | | | |
Hurlow, 1980 | ticlopidine | placebo | | 60 (30/30) | | | |
Berglund, 1985 | ticlopidine | placebo | | 38 (21/17) | Exploratory | | |
Krause, 1980 | ticlopidine | placebo | | 38 (19/19) | | | |
Katsumara, 1982 | ticlopidine | placebo | | 193 (93/100) | | | |
Birmingham-A, 1979 | ticlopidine | placebo | | 28 (20/8) | | | |
Aukland, 1982 | ticlopidine | placebo | | 65 (33/32) | | | |
London diabetes, 1983 | ticlopidine | placebo | | 78 (38/40) | | | |
Stiegler, 1984 | ticlopidine | placebo | | 114 (57/57) | | | |
TIMAD, 1984 | ticlopidine | placebo | | 435 (220/215) | | | |
BTRS, 1992 | ticlopidine | placebo | | 100 (49/51) | | | |
Nyberg, 1984 | ticlopidine | placebo | | 23 (12/11) | Confirmatory | | |
Cloarec, 1986 | ticlopidine | placebo | | 132 (66/66) | | | |
Arcan, 1988 | ticlopidine | placebo | | 169 (83/86) | | | |
Balsano, 1989 | ticlopidine | placebo | | 151 (76/75) | | | |
STIMS, 1990 | ticlopidine | placebo | | 687 (346/341) | | | |
EMATAP, 1993 | ticlopidine | placebo | | 615 (304/311) | | | |
Coronary artery disease - death and events prevention in all type of patients |
Berglund, 1985 | ticlopidine | placebo | | 38 (21/17) | Exploratory | | |
Diabetes type 2 - antiplatelets drug in patients without cardiovascular disease - antiplatelets drug in all type of patients |
Birmingham-A, 1979 | ticlopidine | placebo | | 28 (20/8) | | | |
London diabetes, 1983 | ticlopidine | placebo | | 78 (38/40) | | | |
TIMAD, 1984 | ticlopidine | placebo | | 435 (220/215) | | | |
BTRS, 1992 | ticlopidine | placebo | | 100 (49/51) | | | |
Nyberg, 1984 | ticlopidine | placebo | | 23 (12/11) | Confirmatory | | |
Percutaneous coronary intervention - antithrombotics in all type of patients - antithrombotics in PCI with stent placement - antiplatelets drug in all type of patients |
TACT, 1990 | ticlopidine | placebo | | 350 (177/173) | | | |
White (ticlopidine), 1991 | ticlopidine | placebo | | NA | | | |
STARS (vs aspirin), 1998 | ticlopidine + aspirin | aspirin | | 1103 (546/557) | | | |
Hall, 1996 | ticlopidine + aspirin | aspirin | | 116 (13/103) | | | |
STARS (vs coumadin+asp), 1998 | ticlopidine + aspirin | coumadin + aspirin | | 1096 (546/550) | | | |
FANTASTIC, 1998 | ticlopidine + aspirin | coumadin + aspirin | | 473 (243/230) | | | |
ISAR, 1996 | ticlopidine + aspirin | coumadin + aspirin | | 517 (257/260) | | | |
MATTIS, 1998 | ticlopidine + aspirin | coumadin + aspirin | | 350 (177/173) | | | |
Foussas, 2000 | ticlopidine + aspirin | coumadin + aspirin | | 404 (203/201) | | | |
Peripheral vascular diseases - antiplatelets drug in all type of patient - antithrombotics in after revascularisation |
Becquemin, 1997 | ticlopidine | contrôle | | 243 (122/121) | | | |
Ellis, 1986 | ticlopidine | placebo | | 203 (100/103) | | | |
Hurlow, 1980 | ticlopidine | placebo | | 60 (30/30) | | | |
Krause, 1980 | ticlopidine | placebo | | 38 (19/19) | | | |
Katsumara, 1982 | ticlopidine | placebo | | 193 (93/100) | | | |
Aukland, 1982 | ticlopidine | placebo | | 65 (33/32) | | | |
Stiegler, 1984 | ticlopidine | placebo | | 114 (57/57) | | | |
Cloarec, 1986 | ticlopidine | placebo | | 132 (66/66) | | | |
Arcan, 1988 | ticlopidine | placebo | | 169 (83/86) | | | |
Balsano, 1989 | ticlopidine | placebo | | 151 (76/75) | | | |
STIMS, 1990 | ticlopidine | placebo | | 687 (346/341) | | | |
EMATAP, 1993 | ticlopidine | placebo | | 615 (304/311) | | | |
Stable angina - antithrombotics in all type of patient |
Berglund, 1985 | ticlopidine | placebo | | 38 (21/17) | Exploratory | | |
Stent - antithrombotics in all type of patients |
STARS (vs aspirin), 1998 | ticlopidine + aspirin | aspirin | | 1103 (546/557) | | | |
Hall, 1996 | ticlopidine + aspirin | aspirin | | 116 (13/103) | | | |
STARS (vs coumadin+asp), 1998 | ticlopidine + aspirin | coumadin + aspirin | | 1096 (546/550) | | | |
FANTASTIC, 1998 | ticlopidine + aspirin | coumadin + aspirin | | 473 (243/230) | | | |
ISAR, 1996 | ticlopidine + aspirin | coumadin + aspirin | | 517 (257/260) | | | |
MATTIS, 1998 | ticlopidine + aspirin | coumadin + aspirin | | 350 (177/173) | | | |
Foussas, 2000 | ticlopidine + aspirin | coumadin + aspirin | | 404 (203/201) | | | |
Thrombosis prevention - antithrombotics in general surgery - antiplatelets drug in general surgery - antiplatelets drug in all type of patients - antithrombotics in orthopedic surgery - antiplatelets drug in orthopedic surgery - antiplatelets drug in elective orthopedic surgery - antithrombotics in medical patients - antiplatelets drug in medical patients |
Lasierra, 1982 | ticlopidine | placebo | | 80 (40/40) | Exploratory | | |
Walker, 1974 | ticlopidine | placebo | | 64 (31/33) | Exploratory | | |
McKenna-II, 1983 | Ticlopidine | placebo | | 58 (29/29) | Exploratory | | |
Lyon-II | Ticlopidine | placebo | | 40 (20/20) | Exploratory | | |
Gardecki | Ticlopidine | placebo | | 94 (48/46) | Exploratory | | |
McKenna-II , 1983 | ticlopidine | placebo | | 53 (27/26) | | | |